AAT Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.
Synonyms
Serpin A1; Short peptide from AAT; SPAAT; AAT.
Gene ID
5265
Swiss Prot
P01009
Cellular Locus
Extracellular, Secreted
Host
Rabbit
Cross Reactivity
Human
Target
AAT
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human Antithrombin 3
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5265
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
222362-01 50 µL
EHMT2 (Histone-lysine N-Methyltransferase EHMT2, Euchromatic histone-lysine N-Methyltransferase 2, HLA-B-Associated transcript 8, Histone H3-K9 Methyltransferase 3, H3-K9-HMTase 3, Lysine N-Methyltransferase 1C, Protein G9a, EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36) discontinued
Ask
View Details